{"id":904,"date":"2013-08-10T23:55:14","date_gmt":"2013-08-11T03:55:14","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/inmuno\/?p=904"},"modified":"2013-08-10T23:55:14","modified_gmt":"2013-08-11T03:55:14","slug":"interleukin-6-a-new-therapeutic-target-in-systemic-sclerosis","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/inmuno\/2013\/08\/10\/interleukin-6-a-new-therapeutic-target-in-systemic-sclerosis\/","title":{"rendered":"Interleukin-6: a new therapeutic target in systemic sclerosis?"},"content":{"rendered":"<p><a href=\"http:\/\/www.nature.com\/cti\/journal\/v2\/n4\/full\/cti20132a.html\" target=\"_blank\">Clinical &amp; Translational Immunology (2013) 2, e4; doi:10.1038\/cti.2013.2<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical &amp; Translational Immunology (2013) 2, e4; doi:10.1038\/cti.2013.2.<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,24],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/904"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/comments?post=904"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/904\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/media?parent=904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/categories?post=904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/tags?post=904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}